Efficacy of ilaprazole in the treatment of duodenal ulcers: A meta-analysis

Table 2 Results of the randomized controlled trials with intention-to-treat analysis

Ref.	Regimen	4-wk healing rate	Rate of adverse effects
Ho et al[17], 2009	I 10 mg/d	78.6% (77/98)	23.5% (23/98)
	O 20 mg/d	78.8% (82/104)	22.1% (23/104)
Zhou et al[19],2009	I 10 mg/d	90.3% (307/340)	8.2% (28/340)
	O 20 mg/d	87.6% (149/170)	11.2% (19/170)
Song et al[18], 2010	I 10 mg/d	85.9% (67/78)	6.4% (5/78)
	E 40 mg/d	87.2% (68/78)	7.5% (6/78)
Wang et al[23], 2011	I 10 mg/d	93.1% (54/58)	6.9% (4/58)
	O 20 mg/d	89.8% (53/59)	13.6% (8/59)
Wang et al[24], 2012	I 10 mg/d	95.0% (307/331)	8.5% (28/331)
	O 20 mg/d	90.0% (149/165)	11.6% (19/165)

I: Ilaprazole; O: Omeprazole; E: Esomeprazole.